These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 25068521)

  • 1. Hypomagnesaemia and hypocalcaemia in a patient with systemic sclerosis: role of proton pump inhibitors.
    Perez MO; Neves EF; Bortolai CB; Sampaio-Barros PD; Andrade DC; Seguro LP
    Clin Exp Rheumatol; 2014; 32(6 Suppl 86):S-225-7. PubMed ID: 25068521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severe hypomagnesaemia in long-term users of proton-pump inhibitors.
    Cundy T; Dissanayake A
    Clin Endocrinol (Oxf); 2008 Aug; 69(2):338-41. PubMed ID: 18221401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Profound hypomagnesaemia causing symptomatic hypocalcaemia--an underdiagnosed and potentially life-threatening problem in systemic sclerosis?
    Low AS; Lal S; Farrell AJ; Herrick AL
    Rheumatology (Oxford); 2014 Apr; 53(4):767-9. PubMed ID: 24196390
    [No Abstract]   [Full Text] [Related]  

  • 4. An approach to the diagnosis and management of a case presenting with recurrent hypomagnesemia secondary to the chronic use of a proton pump inhibitor.
    dos Santos LM; Guerra RA; Lazaretti-Castro M; Vieira JG; Portes Ede S; Dias-da-Silva MR
    Magnes Res; 2015 Dec; 28(4):136-45. PubMed ID: 26878253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [An unknown but potentially serious side effect of proton pump inhibitors: hypomagnesaemia].
    Doornebal J; Bijlsma R; Brouwer RM
    Ned Tijdschr Geneeskd; 2009; 153():A711. PubMed ID: 19930736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Severe hypomagnesaemia due to proton pump inhibitor use].
    van den Berg S; Scheer MLJ; Holman ND
    Ned Tijdschr Geneeskd; 2018 Aug; 162():. PubMed ID: 30182626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypomagnesaemia due to proton-pump inhibitor therapy: a clinical case series.
    Mackay JD; Bladon PT
    QJM; 2010 Jun; 103(6):387-95. PubMed ID: 20378675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypomagnesaemia due to use of proton pump inhibitors--a review.
    Kuipers MT; Thang HD; Arntzenius AB
    Neth J Med; 2009 May; 67(5):169-72. PubMed ID: 19581665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hypomagnesaemia and hypocalcemia-induced by omeprazole].
    Lefort A; Arlet P; Bagheri H; Campistron E
    Therapie; 2012; 67(2):191-2. PubMed ID: 22850108
    [No Abstract]   [Full Text] [Related]  

  • 10. Prevalence and predictors of proton pump inhibitor partial response in gastroesophageal reflux disease in systemic sclerosis: a prospective study.
    Foocharoen C; Chunlertrith K; Mairiang P; Mahakkanukrauh A; Suwannaroj S; Namvijit S; Wantha O; Nanagara R
    Sci Rep; 2020 Jan; 10(1):769. PubMed ID: 31964957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistent severe hypomagnesemia caused by proton pump inhibitor resolved after laparoscopic fundoplication.
    Semb S; Helgstrand F; Hjørne F; Bytzer P
    World J Gastroenterol; 2017 Oct; 23(37):6907-6910. PubMed ID: 29085234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Omeprazole-induced hypomagnesaemia, causing renal tubular acidosis with hypokalaemia, hypocalcaemia, hyperlactacidaemia and hyperammonaemia.
    Isse N; Hashimoto M
    BMJ Case Rep; 2020 Jul; 13(7):. PubMed ID: 32641306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concomitant Administration of a Histamine2 Receptor Antagonist and Proton Pump Inhibitor Enhances Gastric Acid Suppression.
    Abdul-Hussein M; Freeman J; Castell D
    Pharmacotherapy; 2015 Dec; 35(12):1124-9. PubMed ID: 26621819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of alginic acid in combination with proton pump inhibitor for the treatment of gastroesophageal reflux disease in systemic sclerosis patients.
    Foocharoen C; Kingkaew P; Teerawattananon Y; Mahakkanukrauh A; Suwannaroj S; Manasirisuk W; Chaiyarit J; Sangchan A
    Int J Rheum Dis; 2023 Oct; 26(10):2037-2046. PubMed ID: 37665078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and outcomes of proton pump inhibitor associated hypomagnesemia in chronic kidney disease.
    Hughes J; Y Y Chiu D; Kalra PA; Green D
    PLoS One; 2018; 13(5):e0197400. PubMed ID: 29799851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hypomagnesemia and hypocalcemia associated with chronic omeprazole use].
    Cuesta Miyares J; López Caleya JF; Martín Rodrigo L
    Semergen; 2020; 46(1):e1-e2. PubMed ID: 31785990
    [No Abstract]   [Full Text] [Related]  

  • 17. Dietary Inulin Fibers Prevent Proton-Pump Inhibitor (PPI)-Induced Hypocalcemia in Mice.
    Hess MW; de Baaij JH; Gommers LM; Hoenderop JG; Bindels RJ
    PLoS One; 2015; 10(9):e0138881. PubMed ID: 26397986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe symptomatic hypomagnesaemia induced by the chronic use of proton pump inhibitors: a case report of a patient with Zollinger-Ellison syndrome.
    Ströker E; Leone L; Vandeput Y; Borbath I; Lefebvre C
    Acta Clin Belg; 2014; 69(1):62-5. PubMed ID: 24635401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inulin significantly improves serum magnesium levels in proton pump inhibitor-induced hypomagnesaemia.
    Hess MW; de Baaij JH; Broekman M; Bisseling TM; Haarhuis B; Tan A; Te Morsche R; Hoenderop JG; Bindels RJ; Drenth JP
    Aliment Pharmacol Ther; 2016 Jun; 43(11):1178-85. PubMed ID: 27086738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized controlled trial comparing the efficacy of mosapride plus omeprazole combination therapy to omeprazole monotherapy in gastroesophageal reflux disease.
    Yamaji Y; Isomura Y; Yoshida S; Yamada A; Hirata Y; Koike K
    J Dig Dis; 2014 Sep; 15(9):469-76. PubMed ID: 24957863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.